LGM
Logos Global Management Portfolio holdings
AUM
$749M
This Quarter Return
+80.86%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$353M
AUM Growth
–
Cap. Flow
+$353M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
58.7%
Holding
38
New
38
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$32.7M |
| 2 |
Sarepta Therapeutics
SRPT
|
$29.2M |
| 3 |
Ascendis Pharma
ASND
|
$25M |
| 4 |
AMRN
Amarin Corp
AMRN
|
$20.6M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$18M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 94.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Assembly Biosciences
ASMB
$183M
| $3.85M | 0.95% |
+15,667
| New | +$3.85M |
|
|
BLU
27
DELISTED
BELLUS Health Inc.
BLU
| $3.23M | 0.8% |
+424,618
| New | +$3.23M |
|
|
KRTX
28
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.99M | 0.74% |
+39,647
| New | +$2.99M |
|
|
APTO
29
DELISTED
Aptose Biosciences, Inc.
APTO
| $2.97M | 0.73% |
+1,164
| New | +$2.97M |
|
30
MEI Pharma
MEIP
$149M
| $2.84M | 0.7% |
+57,276
| New | +$2.84M |
|
31
Madrigal Pharmaceuticals
MDGL
$9.7B
| $2.49M | 0.61% |
+27,279
| New | +$2.49M |
|
32
Savara
SVRA
$591M
| $2.48M | 0.61% |
+613,999
| New | +$2.48M |
|
33
89bio
ETNB
$1.37B
| $2.28M | 0.56% |
+86,591
| New | +$2.28M |
|
34
Fulcrum Therapeutics
FULC
$353M
| $2.06M | 0.51% |
+123,635
| New | +$2.06M |
|
35
Minerva Neurosciences
NERV
$16.8M
| $1.62M | 0.4% |
+28,479
| New | +$1.62M |
|
36
Ardelyx
ARDX
$1.57B
| $1.59M | 0.39% |
+212,449
| New | +$1.59M |
|
37
Neurogene
NGNE
$284M
| $499K | 0.12% |
+2,026
| New | +$499K |
|
38
Kezar Life Sciences
KZR
$28.5M
| $493K | 0.12% |
+12,293
| New | +$493K |
|